EXACT Sciences Corporation · Marlborough, MA United States (NASDAQ: EXAS)
| 100 Campus Dr. | Phone: 508-683-1200 |
| Marlborough, MA | Fax: 508-683-1201 |
| 01752 | |
| United States | 
Map This Company |
EXACT Sciences Corporation Rankings
Company Description
Guesstimates aren't good enough when diagnosing a deadly cancer, so EXACT Sciences aims for accuracy. The firm develops non-invasive tests for the early detection of colorectal cancer and precancerous lesions. Its products isolate DNA in stool samples, using its Effipure technology, then identify genetic mutations associated with cancer. Colorectal cancer is a common (and one of the deadliest) cancers, and EXACT believes its method is superior to existing diagnostic methods because it may be able to discern colorectal cancer in its early stages, when it is most treatable. However, facing several product development setbacks, the company is undergoing a strategic reorganization.
EXACT Sciences Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: EXAS Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 35 |
Executives
11 executives listed for EXACT Sciences Corporation's Marlborough, MA location.
| Chairman | Patrick Zenner | |
|---|---|---|
| President, CEO, and Director | Kevin Conroy | |
| SVP and CFO | Maneesh Arora |